<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399451</url>
  </required_header>
  <id_info>
    <org_study_id>LYZXYY06002</org_study_id>
    <secondary_id>ACTRNO12606000444583</secondary_id>
    <nct_id>NCT00399451</nct_id>
  </id_info>
  <brief_title>Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)</brief_title>
  <official_title>Preliminary Study on Submucous Sclerosis of Pharynges With 1% Polidocanol to Treat Obstructive Sleep Apnea (OSA) &amp; Snoring Subjects (SS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Liaoyang Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Liaoyang Central Hospital</source>
  <brief_summary>
    <textblock>
      The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of
      pharynx for OSAS &amp; SS,to reduce pharyngeal compliance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection.The
      injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral
      pharyngeal submucosa and in front submucosa of soft palate.The injection is multi-point,and
      each point injection is 0.3~0.5ml;the total quantity/each time is not more than 5ml.Every
      patient have to be treated about 1~2 time.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2006</start_date>
  <completion_date>June 2009</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>apnea-hypopnea index (AHI)is on polysomnography(PSG),to compare AHIanterior and posterior treatment.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial oxygen saturation (SaO2) and body mass index (BMI)will be measured on polysomnography</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Apnea</condition>
  <condition>Snoring</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polidocanol Sclerotherapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OSAS &amp; SS which palatopharyngeal collapse.

        Exclusion Criteria:

          -  obstructive sleep apnea syndrome (osas) &amp; snoring subjects (ss),which anatomic narrow
             result in.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Youliang YIN, MB</last_name>
    <role>Study Director</role>
  </overall_official>
  <overall_contact>
    <last_name>Hongyan Chen, MB</last_name>
    <phone>+86-0419-3221423</phone>
    <email>lychy2006@yahoo.com.cn</email>
  </overall_contact>
  <verification_date>November 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2006</study_first_submitted>
  <study_first_submitted_qc>November 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2006</study_first_posted>
  <last_update_submitted>November 20, 2006</last_update_submitted>
  <last_update_submitted_qc>November 20, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2006</last_update_posted>
  <keyword>Sleep Apnea,Obstructive</keyword>
  <keyword>apnea-hypopnea index (AHI)</keyword>
  <keyword>polidocanol</keyword>
  <keyword>sclerotherapy</keyword>
  <keyword>pharynges</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Snoring</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polidocanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

